Schering European appointments
This article was originally published in The Tan Sheet
Executive Summary
Claritin marketer has appointed Hanz Fritz, PhD, VP and general manager for the German business Essex Pharma, Schering announces June 15; Fritz is leaving Novartis after 14 years in senior-level management positions for the Schering post. Gordon Coutts, MD, has been named VP and general manager for the UK and Ireland. Coutts previously worked at Eli Lilly as Managing Director, Belgium and Luxembourg. Ratnakar Mitra moves up the ranks to VP Europe Area II, based in Lucerne, Switzerland; Mitra has been at Schering for 24 years. Marc Princen was appointed Regional Director for the Central and Eastern European region, also based in Lucerne, Switzerland. He formerly was VP and general manager of the German business...
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.